FDA approval of mirdametinib for NF1-associated plexiform neurofibromas: clinical and regulatory perspectives. [PDF]
Sheikh M +3 more
europepmc +1 more source
Subtype distribution, clinical presentation, and molecular spectrum of neurofibromatosis type 1-associated breast cancer. [PDF]
Di Giosaffatte N +38 more
europepmc +1 more source
NF1 with Multiple Cardiac Structural Abnormalities Leading to Cerebral Infarction. [PDF]
Ye J, Jiang Y, Wang H, Wang D.
europepmc +1 more source
A novel multion in a Chinese family with neurofibromatosis type 1: A case report. [PDF]
Tao X, Yang X, Huang X, Fan M, Wang Z.
europepmc +1 more source
Optic Nerve Glioma, Plexiform Neurofibroma, and Secondary Glaucoma in a Child With a Rare NF1 Variant (p.Gln83Ter): A Case Report. [PDF]
Chaudhary K, Dubey S.
europepmc +1 more source
Molecular Analysis of Neurofibromin Deficient Muscle
The genetic disease neurofibromatosis type 1 (NF1) is classically associated with central nervous system and tumour manifestations. However, recent clinical and basic studies have confirmed anecdotal reports of muscle weakness associated with NF1, which can have substantial impact on quality of life.
openaire +1 more source
Excessive intraoperative hemorrhage during orthognathic surgery in a patient with neurofibromatosis type 1: a case report and literature review. [PDF]
Sasahara N +5 more
europepmc +1 more source
Alternative Splicing of Exon 23a in Neurofibromatosis Type 1 Pre-mRNA: Its Contribution to the Protein Structure and Function of Neurofibromin. [PDF]
Elsner Pacheco AG, Lou H.
europepmc +1 more source
<i>MAP3K7CL</i> Inhibits the Inflammatory Responses in Goose Fatty Liver. [PDF]
Zhao M +6 more
europepmc +1 more source
Neurofibromin 1 (<i>NF1</i>) Splicing Mutation c.61-2A>G: From Aberrant mRNA Processing to Therapeutic Implications In Silico. [PDF]
Blazyte A +12 more
europepmc +1 more source

